Total Payments
$1,249
2023 Payments
$133.13
Companies
17
Transactions
56
Medicare Patients
5,948
Medicare Billing
$392,963
Payment Breakdown by Category
Food & Beverage$1,112 (89.1%)
Education$120.95 (9.7%)
Other$15.72 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,112 | 53 | 89.1% |
| Education | $120.95 | 2 | 9.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15.72 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $173.97 | 14 | $0 (2022) |
| Sirtex Medical Inc | $160.52 | 2 | $0 (2022) |
| Kite Pharma, Inc. | $127.67 | 8 | $0 (2023) |
| Global Blood Therapeutics, Inc. | $125.69 | 6 | $0 (2022) |
| Celgene Corporation | $121.30 | 8 | $0 (2022) |
| Rigel Pharmaceuticals, Inc. | $115.73 | 1 | $0 (2021) |
| Seagen Inc. | $99.95 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $66.89 | 3 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $46.19 | 1 | $0 (2017) |
| PFIZER INC. | $44.20 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $133.13 | 7 | Astellas Pharma US Inc ($38.97) |
| 2022 | $447.03 | 32 | E.R. Squibb & Sons, L.L.C. ($173.97) |
| 2021 | $409.90 | 11 | Rigel Pharmaceuticals, Inc. ($115.73) |
| 2018 | $30.20 | 2 | Sanofi Pasteur Inc. ($15.72) |
| 2017 | $228.60 | 4 | Sirtex Medical Inc ($144.58) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2023 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Oncology | ||||||
| 08/15/2023 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: HEMATOLOGY | ||||||
| 07/25/2023 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Oncology | ||||||
| 06/26/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Hematology | ||||||
| 03/24/2023 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $15.50 | General |
| 03/01/2023 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $13.70 | General |
| 02/27/2023 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/12/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.26 | General |
| Category: Oncology | ||||||
| 12/12/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $0.01 | General |
| Category: Oncology | ||||||
| 10/17/2022 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $25.15 | General |
| Category: Hematology | ||||||
| 08/29/2022 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $12.58 | General |
| 08/05/2022 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $23.64 | General |
| Category: Hematology | ||||||
| 07/28/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $25.63 | General |
| 07/28/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $4.31 | General |
| 07/22/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.51 | General |
| Category: Oncology | ||||||
| 07/22/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $1.82 | General |
| Category: Oncology | ||||||
| 07/18/2022 | Veracyte, Inc. | — | Food and Beverage | In-kind items and services | $13.02 | General |
| 06/23/2022 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $25.16 | General |
| Category: Hematology | ||||||
| 06/15/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $26.56 | General |
| 06/14/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Sickle Cell Disease | ||||||
| 06/13/2022 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $18.21 | General |
| 06/10/2022 | Sobi, Inc | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/17/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $30.20 | General |
| 05/17/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $3.02 | General |
| 05/10/2022 | Celgene Corporation | ONUREG (Drug) | Food and Beverage | Cash or cash equivalent | $26.94 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 2,727 | 26,651 | $899,677 | $162,483 |
| 2022 | 37 | 2,279 | 15,991 | $993,512 | $153,065 |
| 2021 | 22 | 697 | 7,937 | $323,053 | $50,326 |
| 2020 | 8 | 245 | 538 | $89,521 | $27,090 |
Total Patients
5,948
Total Services
51,117
Medicare Billing
$392,963
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 404 | $185,280 | $44,187 | 23.8% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2023 | 31 | 765 | $82,620 | $17,395 | 21.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 66 | 315 | $47,250 | $16,751 | 35.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 41 | 135 | $67,500 | $8,225 | 12.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 43 | $40,420 | $7,064 | 17.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $23,800 | $6,048 | 25.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 229 | 706 | $14,120 | $5,922 | 41.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 227 | 662 | $99,300 | $5,038 | 5.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 160 | 282 | $42,300 | $3,754 | 8.9% |
| 83521 | Measurement of immunoglobulin light chains | Office | 2023 | 78 | 200 | $14,000 | $3,385 | 24.2% |
| J1756 | Injection, iron sucrose, 1 mg | Office | 2023 | 32 | 20,400 | $25,500 | $3,265 | 12.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 131 | 211 | $15,825 | $3,119 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 42 | $12,600 | $2,921 | 23.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 13 | 23 | $12,650 | $2,761 | 21.8% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Office | 2023 | 93 | 120 | $13,200 | $2,627 | 19.9% |
| 83550 | Iron binding capacity | Office | 2023 | 160 | 282 | $35,250 | $2,408 | 6.8% |
| 88184 | Flow cytometry technique for dna or cell analysis, first marker | Office | 2023 | 31 | 33 | $9,900 | $2,374 | 24.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 130 | 216 | $12,960 | $2,236 | 17.3% |
| 81279 | Gene analysis (janus kinase 2) targeted sequence analysis | Office | 2023 | 11 | 11 | $8,151 | $1,997 | 24.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 45 | 159 | $30,210 | $1,986 | 6.6% |
| 80074 | Acute hepatitis panel | Office | 2023 | 40 | 42 | $7,350 | $1,961 | 26.7% |
| 83540 | Iron level | Office | 2023 | 160 | 281 | $19,670 | $1,776 | 9.0% |
| 81338 | Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants | Office | 2023 | 11 | 11 | $6,622 | $1,621 | 24.5% |
| 81219 | Gene analysis (calreticulin), common variants | Office | 2023 | 11 | 11 | $5,390 | $1,311 | 24.3% |
| 84165 | Protein measurement, serum | Office | 2023 | 94 | 122 | $7,320 | $1,285 | 17.6% |
About Dr. David Askin, D.O
Dr. David Askin, D.O is a Hematology & Oncology healthcare provider based in Forest Hills, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1043424542.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Askin, D.O has received a total of $1,249 in payments from pharmaceutical and medical device companies, with $133.13 received in 2023. These payments were reported across 56 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,112).
As a Medicare-enrolled provider, Askin has provided services to 5,948 Medicare beneficiaries, totaling 51,117 services with total Medicare billing of $392,963. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Forest Hills, NY
- Active Since 05/10/2007
- Last Updated 03/29/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1043424542
Products in Payments
- SIR-Spheres Microspheres (Device) $160.52
- OXBRYTA (Drug) $148.89
- Tavalisse (Drug) $115.73
- REBLOZYL (Biological) $73.95
- OPDIVO (Biological) $60.12
- ONUREG (Drug) $47.35
- TAGRISSO (Drug) $46.19
- LUTATHERA (Drug) $43.35
- Xospata (Drug) $38.97
- DOPTELET (Drug) $32.84
- ZENPEP (Drug) $28.77
- Vonjo (Drug) $24.93
- KISQALI (Drug) $23.54
- ORGOVYX (Drug) $21.00
- NO PRODUCT DISCUSSED (Drug) $15.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Forest Hills
Ewa Matczak, Md, MD
Hematology & Oncology — Payments: $287,791
Hematology & Oncology $287,791
Dr. Vladimir Gotlieb, Md, MD
Hematology & Oncology — Payments: $85,447
Hematology & Oncology $85,447
Jane Daly, Md, MD
Hematology & Oncology — Payments: $8,156
Hematology & Oncology $8,156
Dr. Dhvani Thakker, M.d, M.D
Hematology & Oncology — Payments: $2,416
Hematology & Oncology $2,416
George Spanos, Md, MD
Hematology & Oncology — Payments: $378.13
Hematology & Oncology $378.13
Shanta Bajaj, Md, MD
Hematology & Oncology — Payments: $302.61
Hematology & Oncology $302.61